PBT2 News, page-6

Thanks lwlinwei ! Good info. McDevitt is one of the inventors so he has the biggest interest with his 3 co-inventors. It is clear that they and QU will be pushing forward with the studies needed: pharmacokinetics, other bacteria, other PBT2 drug combinations. Pharmacokinetics are IMO done first in animals and that may be a reason no studies are registered in the Australian New Zealand clinical trials registry. But I think the needed animal studies were already at least partly done with these newly published studies. So I think that within a few months there will be something in this registry indicating the start of human studies. ATH will be in a side role waiting for the milestones and royalties as we here on this board.